Innoviva Change To Liabilities vs Cash And Cash Equivalents Changes Analysis

INVA Stock

USD 18.99 0.06 0.31%

Innoviva financial indicator trend analysis is infinitely more than just investigating Innoviva recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Innoviva is a good investment. Please check the relationship between Innoviva Change To Liabilities and its Cash And Cash Equivalents Changes accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.

Change To Liabilities vs Cash And Cash Equivalents Changes

Change To Liabilities vs Cash And Cash Equivalents Changes Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Innoviva Change To Liabilities account and Cash And Cash Equivalents Changes. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Innoviva's Change To Liabilities and Cash And Cash Equivalents Changes is -0.35. Overlapping area represents the amount of variation of Change To Liabilities that can explain the historical movement of Cash And Cash Equivalents Changes in the same time period over historical financial statements of Innoviva, assuming nothing else is changed. The correlation between historical values of Innoviva's Change To Liabilities and Cash And Cash Equivalents Changes is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Liabilities of Innoviva are associated (or correlated) with its Cash And Cash Equivalents Changes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Cash Equivalents Changes has no effect on the direction of Change To Liabilities i.e., Innoviva's Change To Liabilities and Cash And Cash Equivalents Changes go up and down completely randomly.

Correlation Coefficient

-0.35

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Change To Liabilities

Cash And Cash Equivalents Changes

Most indicators from Innoviva's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innoviva current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.At present, Innoviva's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 5.50, whereas Discontinued Operations is forecasted to decline to (89.7 M).

Innoviva fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Property Plant And Equipment Gross
Total Assets		0.84	0.71	0.39	0.09	-0.19	0.18	0.13	0.16	0.03	0.34	-0.36	-0.05	-0.12	0.29	0.68	0.97	-0.18	0.09	0.27	0.68	-0.05	0.86	0.02	0.26	-0.36
Total Stockholder Equity	0.84		0.86	0.46	-0.3	-0.37	-0.37	-0.41	0.26	0.23	0.34	0.08	0.12	-0.62	0.42	0.58	0.78	-0.57	-0.44	0.33	0.51	-0.38	0.81	-0.45	0.22	0.08
Retained Earnings	0.71	0.86		0.46	-0.58	-0.77	-0.36	-0.37	-0.05	0.08	0.44	0.2	0.0	-0.54	0.26	0.47	0.72	-0.44	-0.42	-0.06	0.49	-0.71	0.64	-0.22	0.08	0.2
Other Assets	0.39	0.46	0.46		0.04	-0.33	-0.21	-0.07	-0.41	-0.49	-0.09	-0.3	-0.3	-0.27	-0.48	0.49	0.43	-0.24	-0.09	-0.21	0.74	-0.22	0.33	-0.15	0.66	-0.3
Common Stock Shares Outstanding	0.09	-0.3	-0.58	0.04		0.77	0.7	0.7	-0.07	-0.39	-0.25	-0.86	-0.25	0.65	-0.29	0.13	0.08	0.51	0.73	0.11	0.33	0.92	-0.06	0.36	0.4	-0.86
Other Stockholder Equity	-0.19	-0.37	-0.77	-0.33	0.77		0.33	0.28	0.32	0.04	-0.32	-0.4	0.11	0.35	0.08	-0.19	-0.26	0.2	0.34	0.43	-0.18	0.92	-0.14	-0.04	0.11	-0.4
Total Liab	0.18	-0.37	-0.36	-0.21	0.7	0.33		0.97	-0.11	-0.28	-0.03	-0.72	-0.28	0.92	-0.24	0.14	0.23	0.76	0.97	-0.1	0.18	0.6	-0.03	0.87	0.05	-0.72
Short Long Term Debt Total	0.13	-0.41	-0.37	-0.07	0.7	0.28	0.97		-0.23	-0.42	-0.2	-0.75	-0.42	0.93	-0.45	0.21	0.18	0.81	0.99	-0.17	0.23	0.56	-0.12	0.91	0.14	-0.75
Other Current Liab	0.16	0.26	-0.05	-0.41	-0.07	0.32	-0.11	-0.23		0.91	0.19	0.4	0.47	-0.25	0.68	0.06	-0.01	-0.39	-0.25	0.78	-0.41	0.09	0.32	-0.32	-0.32	0.4
Total Current Liabilities	0.03	0.23	0.08	-0.49	-0.39	0.04	-0.28	-0.42	0.91		0.3	0.68	0.55	-0.38	0.79	-0.1	-0.11	-0.47	-0.44	0.6	-0.56	-0.2	0.24	-0.35	-0.47	0.68
Other Liab	0.34	0.34	0.44	-0.09	-0.25	-0.32	-0.03	-0.2	0.19	0.3		0.15	0.49	-0.23	0.45	0.09	0.34	-0.42	-0.23	0.06	0.09	-0.33	0.55	-0.15	-0.34	0.15
Property Plant And Equipment Net	-0.36	0.08	0.2	-0.3	-0.86	-0.4	-0.72	-0.75	0.4	0.68	0.15		0.44	-0.64	0.45	-0.31	-0.41	-0.57	-0.78	0.15	-0.67	-0.67	-0.12	-0.49	-0.47	1.0
Current Deferred Revenue	-0.05	0.12	0.0	-0.3	-0.25	0.11	-0.28	-0.42	0.47	0.55	0.49	0.44		-0.4	0.5	-0.07	-0.13	-0.46	-0.41	0.45	-0.47	-0.06	0.18	-0.41	-0.09	0.44
Net Debt	-0.12	-0.62	-0.54	-0.27	0.65	0.35	0.92	0.93	-0.25	-0.38	-0.23	-0.64	-0.4		-0.4	-0.16	-0.03	0.85	0.95	-0.33	0.04	0.59	-0.3	0.88	-0.03	-0.64
Accounts Payable	0.29	0.42	0.26	-0.48	-0.29	0.08	-0.24	-0.45	0.68	0.79	0.45	0.45	0.5	-0.4		-0.13	0.21	-0.5	-0.45	0.44	-0.29	-0.07	0.46	-0.43	-0.41	0.45
Cash	0.68	0.58	0.47	0.49	0.13	-0.19	0.14	0.21	0.06	-0.1	0.09	-0.31	-0.07	-0.16	-0.13		0.59	-0.09	0.15	0.42	0.51	-0.07	0.49	0.09	0.43	-0.31
Non Current Assets Total	0.97	0.78	0.72	0.43	0.08	-0.26	0.23	0.18	-0.01	-0.11	0.34	-0.41	-0.13	-0.03	0.21	0.59		-0.1	0.15	0.05	0.73	-0.07	0.83	0.11	0.26	-0.41
Non Currrent Assets Other	-0.18	-0.57	-0.44	-0.24	0.51	0.2	0.76	0.81	-0.39	-0.47	-0.42	-0.57	-0.46	0.85	-0.5	-0.09	-0.1		0.82	-0.33	0.05	0.46	-0.54	0.82	0.17	-0.57
Long Term Debt	0.09	-0.44	-0.42	-0.09	0.73	0.34	0.97	0.99	-0.25	-0.44	-0.23	-0.78	-0.41	0.95	-0.45	0.15	0.15	0.82		-0.18	0.22	0.61	-0.14	0.89	0.14	-0.78
Cash And Short Term Investments	0.27	0.33	-0.06	-0.21	0.11	0.43	-0.1	-0.17	0.78	0.6	0.06	0.15	0.45	-0.33	0.44	0.42	0.05	-0.33	-0.18		-0.22	0.24	0.33	-0.34	-0.03	0.15
Net Receivables	0.68	0.51	0.49	0.74	0.33	-0.18	0.18	0.23	-0.41	-0.56	0.09	-0.67	-0.47	0.04	-0.29	0.51	0.73	0.05	0.22	-0.22		0.04	0.48	0.08	0.53	-0.67
Common Stock Total Equity	-0.05	-0.38	-0.71	-0.22	0.92	0.92	0.6	0.56	0.09	-0.2	-0.33	-0.67	-0.06	0.59	-0.07	-0.07	-0.07	0.46	0.61	0.24	0.04		-0.13	0.25	0.26	-0.67
Short Term Investments	0.86	0.81	0.64	0.33	-0.06	-0.14	-0.03	-0.12	0.32	0.24	0.55	-0.12	0.18	-0.3	0.46	0.49	0.83	-0.54	-0.14	0.33	0.48	-0.13		-0.22	-0.04	-0.12
Non Current Liabilities Total	0.02	-0.45	-0.22	-0.15	0.36	-0.04	0.87	0.91	-0.32	-0.35	-0.15	-0.49	-0.41	0.88	-0.43	0.09	0.11	0.82	0.89	-0.34	0.08	0.25	-0.22		-0.02	-0.49
Other Current Assets	0.26	0.22	0.08	0.66	0.4	0.11	0.05	0.14	-0.32	-0.47	-0.34	-0.47	-0.09	-0.03	-0.41	0.43	0.26	0.17	0.14	-0.03	0.53	0.26	-0.04	-0.02		-0.47
Property Plant And Equipment Gross	-0.36	0.08	0.2	-0.3	-0.86	-0.4	-0.72	-0.75	0.4	0.68	0.15	1.0	0.44	-0.64	0.45	-0.31	-0.41	-0.57	-0.78	0.15	-0.67	-0.67	-0.12	-0.49	-0.47

Click cells to compare fundamentals

Innoviva Account Relationship Matchups

Innoviva fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	724.8M	999.6M	926.4M	1.2B	1.2B	1.3B
Total Stockholder Equity	313.5M	539.9M	414.7M	565.8M	675.0M	708.7M
Retained Earnings	(946.4M)	(722.0M)	(456.1M)	(204.9M)	(25.2M)	(26.4M)
Other Assets	293.6M	657.5M	425.2M	198.5M	228.2M	131.6M
Common Stock Shares Outstanding	113.4M	113.6M	94.3M	95.2M	86.9M	81.9M
Liabilities And Stockholders Equity	724.8M	999.6M	926.4M	1.2B	1.2B	1.3B
Other Stockholder Equity	1.3B	1.3B	870.2M	770.0M	699.5M	1.0B
Total Liab	382.7M	391.7M	400.5M	665.7M	568.6M	442.4M
Short Long Term Debt Total	377.1M	410.5M	394.7M	637.9M	449.1M	332.2M
Other Current Liab	5.4M	6.0M	5.7M	31.7M	17.2M	12.9M
Total Current Liabilities	5.4M	6.1M	5.8M	38.8M	38.1M	25.0M
Other Liab	586K	219K	106K	84.2M	75.8M	49.3M
Property Plant And Equipment Net	33K	28K	12K	3.4M	3.0M	2.9M
Net Debt	99.0M	139.0M	193.1M	346.8M	255.6M	192.9M
Accounts Payable	10K	66K	27K	2.9M	6.7M	7.1M
Cash	278.1M	246.5M	201.5M	291.0M	193.5M	138.1M
Non Current Assets Total	293.6M	657.5M	612.7M	788.0M	899.3M	944.3M
Non Currrent Assets Other	139.4M	214K	108K	101.9M	87.1M	68.4M
Long Term Debt	377.1M	385.5M	394.7M	540.4M	446.2M	321.7M
Cash And Short Term Investments	350.8M	246.5M	201.5M	291.0M	193.5M	235.5M
Net Receivables	79.4M	93.9M	110.7M	64.1M	84.1M	88.3M
Common Stock Total Equity	1.0M	1.0M	1.0M	696K	800.4K	857.6K
Short Term Investments	72.7M	438.3M	483.8M	403.0M	463.5M	486.6M
Non Current Liabilities Total	377.3M	385.6M	394.7M	626.9M	530.4M	426.9M
Other Current Assets	80.4M	95.6M	1.4M	32.5M	25.9M	22.6M
Property Plant And Equipment Gross	33K	28K	12K	3.4M	3.0M	2.9M
Total Current Assets	431.2M	342.1M	313.7M	443.5M	344.2M	281.5M
Common Stock	1.0M	1.0M	696K	692K	633K	845.9K
Property Plant Equipment	33K	28K	12K	3.4M	3.1M	2.9M
Inventory	(79.4M)	(93.9M)	(110.7M)	55.9M	40.7M	42.8M
Net Tangible Assets	313.5M	539.9M	414.7M	286.2M	329.1M	345.5M
Noncontrolling Interest In Consolidated Entity	152K	5.5M	67.9M	111.2M	127.9M	134.3M
Retained Earnings Total Equity	(1.5B)	(1.1B)	(722.0M)	(456.1M)	(524.6M)	(550.8M)
Long Term Debt Total	574.4M	382.9M	377.1M	385.5M	443.3M	463.7M
Capital Surpluse	1.3B	1.3B	1.3B	1.3B	1.1B	1.1B
Deferred Long Term Liab	139.1M	125.3M	111.4M	97.6M	112.2M	122.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Innoviva offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innoviva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innoviva Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innoviva Stock:

How To Invest In Innoviva

Details

Is Innoviva Stock a good investment?

Details

What is Innoviva's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innoviva. If investors know Innoviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innoviva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.98)

Earnings Share

0.8

Revenue Per Share

5.6

Quarterly Revenue Growth

0.331

Return On Assets

0.0937

The market value of Innoviva is measured differently than its book value, which is the value of Innoviva that is recorded on the company's balance sheet. Investors also form their own opinion of Innoviva's value that differs from its market value or its book value, called intrinsic value, which is Innoviva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innoviva's market value can be influenced by many factors that don't directly affect Innoviva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Innoviva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innoviva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innoviva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Innoviva Change To Liabilities vs Cash And Cash Equivalents Changes Analysis

Change To Liabilities vs Cash And Cash Equivalents Changes

Change To Liabilities vs Cash And Cash Equivalents Changes Correlation Analysis

Correlation Coefficient

Change To Liabilities

Cash And Cash Equivalents Changes

Innoviva fundamental ratios Correlations

Innoviva Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Innoviva fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Long Term Debt	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.97	Total Assets
Short Long Term Debt Total	+ 0.97	Total Liab
Long Term Debt	+ 0.97	Total Liab
Long Term Debt	+ 0.95	Net Debt

Property Plant And Equipment Gross	- 0.86	Common Stock Shares Outstanding
Property Plant And Equipment Net	- 0.86	Common Stock Shares Outstanding
Property Plant And Equipment Gross	- 0.78	Long Term Debt
Long Term Debt	- 0.78	Property Plant And Equipment Net
Other Stockholder Equity	- 0.77	Retained Earnings
Property Plant And Equipment Gross	- 0.75	Short Long Term Debt Total